Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Recommendation of “Hold” from Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been assigned a consensus recommendation of “Hold” from the five brokerages that are presently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $10.90.

A number of analysts have recently issued reports on the stock. Jefferies Financial Group raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating and raised their price target for the company from $8.00 to $14.00 in a report on Thursday, September 26th. Truist Financial raised their price objective on shares of Pediatrix Medical Group from $10.00 to $13.00 and gave the stock a “hold” rating in a report on Monday, October 7th. UBS Group raised their price objective on shares of Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a report on Friday, August 9th. Finally, StockNews.com raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a report on Wednesday, August 7th.

Pediatrix Medical Group Stock Up 3.1 %

NYSE:MD opened at $12.67 on Thursday. The firm has a market cap of $1.07 billion, a P/E ratio of -14.91, a P/E/G ratio of 1.84 and a beta of 1.56. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.38 and a current ratio of 1.38. Pediatrix Medical Group has a fifty-two week low of $6.62 and a fifty-two week high of $13.01. The firm has a 50-day simple moving average of $11.04 and a two-hundred day simple moving average of $9.11.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.03. The business had revenue of $504.30 million during the quarter, compared to analyst estimates of $505.49 million. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. Pediatrix Medical Group’s revenue was up .7% compared to the same quarter last year. During the same period last year, the business earned $0.37 EPS. Analysts predict that Pediatrix Medical Group will post 1.19 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO C Marc Richards sold 32,562 shares of the business’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $10.08, for a total value of $328,224.96. Following the sale, the chief financial officer now owns 192,785 shares in the company, valued at approximately $1,943,272.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO James D. Swift sold 11,100 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $10.79, for a total value of $119,769.00. Following the sale, the chief executive officer now owns 170,001 shares in the company, valued at approximately $1,834,310.79. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO C Marc Richards sold 32,562 shares of the business’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $10.08, for a total transaction of $328,224.96. Following the completion of the sale, the chief financial officer now owns 192,785 shares in the company, valued at $1,943,272.80. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 68,100 shares of company stock worth $701,889 over the last quarter. Insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Pediatrix Medical Group

Hedge funds and other institutional investors have recently made changes to their positions in the company. nVerses Capital LLC purchased a new stake in shares of Pediatrix Medical Group in the second quarter valued at $31,000. Innealta Capital LLC purchased a new stake in shares of Pediatrix Medical Group in the second quarter valued at $33,000. Nisa Investment Advisors LLC raised its stake in shares of Pediatrix Medical Group by 47.2% in the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock valued at $36,000 after acquiring an additional 1,524 shares during the period. CWM LLC raised its stake in shares of Pediatrix Medical Group by 134.0% in the third quarter. CWM LLC now owns 6,427 shares of the company’s stock valued at $74,000 after acquiring an additional 3,681 shares during the period. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of Pediatrix Medical Group in the second quarter valued at $72,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.